Skip to main content
/asset-v1:FDCRIFABET+FDC001+2017_Oct_FDC001+type@asset+block@WebinarImage4thNov-17.jpg

A promising emerging therapy (RIFAXIMIN) for the treatment of IBS Diarrhoea & SIBO

 

Enroll in FDC001

Offered by FDCRIFABET

FDCRIFABET

Information

  • Price:

    Free

  • Language:

    English

  • Commitment:

Share your Case Studies

Come join our "Learn as you Teach" initiative to democratise healthcare learning by submitting your unique & interesting Case-Studies which will be reviewed by our global medical fraternity as well as an opportunity to be published in leading research journals.

Meet the instructor

Course Staff Image #1

Dr. Philip Abraham

MD, DNB, FCPS, FICP Consultant Gastroenterologist and Hepatologist, P D Hinduja Hospital, and Hinduja Healthcare Surgical, Mumbai. Retired Professor and Head, Department of Gastroenterology, K E M Hospital, Mumbai.

Enroll